Cancer News and Research

Latest Cancer News and Research

HCV more common in West Africa yet lacks equal attention as HIV/AIDS or Ebola

More than 180 million people in the world have hepatitis C, compared with the 34 million with HIV/AIDS and the roughly 30,000 who have had Ebola.

9 Feb 2015

Investigators develop microbiome map of New York City subway system

The microbes that call the New York City subway system home are mostly harmless, but include samples of disease-causing bacteria that are resistant to drugs -- and even DNA fragments associated with anthrax and Bubonic plague -- according to a citywide microbiome map published today by Weill Cornell Medical College investigators.

9 Feb 2015

Two researchers receive Pioneer Award from Human Gene Therapy

Recognized for their pioneering work in the development of gene transfer technology using retroviral vectors to deliver therapeutic genes into cells, Richard C. Mulligan, PhD, Director of the Harvard Gene Therapy Initiative, Harvard Institutes of Medicine, Boston, MA, and A. Dusty Miller, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, received the Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

9 Feb 2015

Abiraterone drug improves survival in prostate cancer patients when given before chemotherapy

Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.

9 Feb 2015

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Researchers from Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology's Program in Speech and Hearing Bioscience and Technology have demonstrated that salicylates, a class of non-steroidal inflammatory drugs (NSAIDs), reduced the proliferation and viability of cultured vestibular schwannoma cells that cause a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

9 Feb 2015

Study reveals how low levels of profilin 1 protein in breast tumours invade other tissues

A new study led by José Javier Bravo-Cordero, Spanish researcher at the Albert Einstein College of Medicine in New York, details how cells with low levels of the profilin 1 protein in breast tumours increase their capacity to metastasise and invade other tissues.

9 Feb 2015

St. Jude Children's Research Hospital to host dedication ceremony of newly renovated Tri Delta Place

St. Jude Children's Research Hospital® will host more than 400 Delta Delta Delta (Tri Delta) women from across the country for a special leadership weekend and formal dedication of the newly renovated St. Jude Tri Delta Place.

9 Feb 2015

Personalized prevention, treatments of cancer now accessible through Stanford University's new genetics course

Instrumental research that aims to enhance how we predict, diagnose and design personalized prevention and treatments of cancer is now accessible through Stanford University's latest professional education course, Understanding Cancer at the Genetic Level.

9 Feb 2015

Diagnosed US Navy veterans, shipyard workers provided instant access to top mesothelioma compensation lawyers

The Mesothelioma Compensation Center is, once again, stepping up for diagnosed victims of mesothelioma exposed to asbestos while serving in the US Navy or at a shipyard, by making them a top priority when it comes to providing instant access to the nation's most skilled compensation attorneys because it is these individuals who deserve the best possible compensation.

9 Feb 2015

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and Jeffrey A. Rivest, MS, President and Chief Executive Officer of University of Maryland Medical Center (UMMC), today announced the official launch of a new "Program in Lung Healing," that will further the School's position as a national leader in research, education and clinical innovation for acute ailments of the lung and respiratory system.

9 Feb 2015

New study suggests that e-cigarette vapors can damage lungs

Do electronic cigarettes help people quit smoking? As the debate continues on that point, a new University of Rochester study suggests that e-cigarettes are likely a toxic replacement for tobacco products.

8 Feb 2015

Medicare coverage of CT lung cancer screening can save more lives

Medicare's final decision to cover computed tomography (CT) lung cancer screening gives seniors at high-risk for the disease access to care that can save more lives than any cancer screening test in history.

8 Feb 2015

Helsinn begins elsiglutide Phase IIB trial for prevention of chemotherapy-induced diarrhea

Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID). The first patients out of a planned total of 600 patients with colorectal cancer treated with chemotherapy have been dosed in the trial.

8 Feb 2015

LA BioMed's Christina Wang receives Mayo H. Soley Award for outstanding research work

Christina Wang, MD, Los Angeles Biomedical Research Institute lead researcher, has received a top honor for her outstanding research work, the Mayo H. Soley Award, at the 2015 Western Regional Meetings of five top research societies in the West.

7 Feb 2015

New compound may lead to development of potential therapeutics for neuropathic pain

A new compound discovered by a team of UC Davis investigators has potent actions against production of a chemical that which is implicated in the development of chronic pain following a peripheral nerve injury in the spinal cord.

7 Feb 2015

41% of the British population unaware of the role of diet in cancer development

Surprising new statistics reveal that 41% of the British population are oblivious to the role that diet plays in the development of cancer - and even those with a family history of the disease are failing to consume potentially "cancer-preventing" compounds in their daily diet.

6 Feb 2015

CLL aggressiveness linked to genetic variability

The genetic variability of a tumour could be a predictor for its aggressiveness: the greater the variability in gene expression, the more aggressive the tumour is likely to be. This is the hypothesis that the CNIO Structural Biology and Biocomputing Programme, led by Alfonso Valencia, is testing, after their findings on chronic lymphocytic leukaemia (CLL), now published in the journal Genome Medicine.

6 Feb 2015

Cancer News and Research

Latest Cancer News and Research

HCV more common in West Africa yet lacks equal attention as HIV/AIDS or Ebola

Investigators develop microbiome map of New York City subway system

Two researchers receive Pioneer Award from Human Gene Therapy

Abiraterone drug improves survival in prostate cancer patients when given before chemotherapy

Salicylates drugs reduce proliferation, viability of cultured vestibular schwannoma cells

Study reveals how low levels of profilin 1 protein in breast tumours invade other tissues

St. Jude Children's Research Hospital to host dedication ceremony of newly renovated Tri Delta Place

Personalized prevention, treatments of cancer now accessible through Stanford University's new genetics course

Diagnosed US Navy veterans, shipyard workers provided instant access to top mesothelioma compensation lawyers

UM SOM launches ‘Program in Lung Healing’ to develop treatments for acute respiratory failure

New study suggests that e-cigarette vapors can damage lungs

Medicare coverage of CT lung cancer screening can save more lives

Helsinn begins elsiglutide Phase IIB trial for prevention of chemotherapy-induced diarrhea

LA BioMed's Christina Wang receives Mayo H. Soley Award for outstanding research work

New compound may lead to development of potential therapeutics for neuropathic pain

41% of the British population unaware of the role of diet in cancer development

CLL aggressiveness linked to genetic variability

Trovagene to sell underwritten public offering of common stock

New study shows that 25% of homeless people in Toronto have vision problems

40% of prison and jail inmates have chronic medical problems, shows BJS survey

Industry Focus eBook - Immunology (3rd edition) eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Immunology (3rd edition) eBook

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Newsletters you may be interested in